Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
hPL-IN-2
Cat. No.:
OB0425LY-196
Appearance:
Solid
Purity:
98.17%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
hPL-IN-2 is a small molecule inhibitor that targets specific targets in order to regulate related physiological processes.
Synonyms:
24900-61-6; 3,5-Dichloro-N-[3-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxybenzamide
CAS No.:
24900-61-6
Compound CID:
154134214
Formula:
C19H11Cl4NO3
Formula Weight:
443.11
Specification
Target:
Lipase
Pathway:
Metabolic enzyme/Protease
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
hPL-IN-2 can be used in basic research, drug screening and metabolic disease modeling, such as experiments related to diabetes and obesity.
